- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT07661407
High-Intensity Laser Therapy (HILT) in Patients With Knee Osteoarthritis
Assessment of the Effectiveness of High-Intensity Laser Therapy (HILT) in the Treatment of Knee Osteoarthritis: A Randomized Placebo-Controlled Trial
Studie Overzicht
Toestand
Conditie
Gedetailleerde beschrijving
Knee osteoarthritis is one of the leading causes of pain and disability among older adults. Although physiotherapy constitutes a cornerstone of conservative management, the clinical effectiveness of High-Intensity Laser Therapy remains uncertain due to methodological heterogeneity of available studies. This prospective randomized placebo-controlled trial will evaluate whether HILT provides additional benefits when combined with standard physiotherapy.
Participants aged 40-75 years with radiographically confirmed mild-to-moderate knee osteoarthritis and pain intensity of at least 4 points on the Visual Analogue Scale will be enrolled. Participants will be randomly assigned in a 1:1 ratio using block randomization. The intervention period will last two weeks. Both groups will receive the same physiotherapy programme consisting of aerobic, strengthening, balance, proprioceptive, stretching, gait and functional exercises. The experimental group will receive active HILT, whereas the control group will receive sham HILT.
Assessments will be performed at baseline, immediately after treatment and 8 weeks after treatment completion.
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studiecontact
- Naam: Paweł Nalborczyk, MSc PT
- Telefoonnummer: +48691219338
- E-mail: pnalborczyk@ur.edu.pl
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Beschrijving
Inclusion Criteria:
- Radiographically confirmed knee osteoarthritis
- Mild-to-moderate disease severity
- Pain ≥4 on VAS for at least 3 months
- Ability to participate in physiotherapy
- Informed consent
Exclusion Criteria:
- Advanced OA requiring surgery
- Previous knee arthroplasty
- Knee instability
- Acute inflammation
- Neurological disorders affecting gait
- Neuropathies or myopathies
- Active inflammatory arthritis
- Recent lower-limb injury (<6 months)
- Intra-articular injections within 3 months
- Cancer, pregnancy, epilepsy
- Electronic implants or pacemaker
- Active local infection
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Dubbele
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Conventional Physiotherapy + HILT
|
Participants will receive a standardized outpatient physiotherapy programme delivered five times per week for two consecutive weeks.
Each session will include aerobic exercise on a stationary bicycle, strengthening exercises, balance and proprioceptive training, functional exercises, stretching exercises, postural exercises, and gait training.
The physiotherapy programme will be identical in both study groups.
Participants will receive High-Intensity Laser Therapy using the ASA Laser HIRO 3.0 device (3 kW).
Treatment will be administered three times per week for two consecutive weeks, resulting in six treatment sessions.
Laser irradiation will be delivered in pulsed mode at a frequency of 20 Hz with a total energy dose of 3000 J per session.
The laser will be applied using a dynamic scanning technique over the anterior, medial, and lateral aspects of the affected knee joint and selected periarticular trigger points.
All procedures will be performed according to a standardized treatment protocol.
Andere namen:
|
|
Sham-vergelijker: Conventional Physiotherapy + Sham HILT
|
Participants will receive a standardized outpatient physiotherapy programme delivered five times per week for two consecutive weeks.
Each session will include aerobic exercise on a stationary bicycle, strengthening exercises, balance and proprioceptive training, functional exercises, stretching exercises, postural exercises, and gait training.
The physiotherapy programme will be identical in both study groups.
o Participants will undergo a sham High-Intensity Laser Therapy procedure using the same ASA Laser HIRO 3.0 device and treatment schedule as the active intervention group.
The handpiece will be positioned and moved over the treatment area in the same manner as during active treatment; however, no therapeutic laser energy will be delivered.
The device will not emit laser radiation, light signals, or audible treatment sounds.
Session frequency, duration, therapist-patient interaction, and treatment environment will be identical to those of the active HILT group.
Andere namen:
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Change in Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain Subscale Score
Tijdsspanne: Baseline, immediately after the 2-week intervention, and 8 weeks after completion of treatment.
|
The Knee Injury and Osteoarthritis Outcome Score (KOOS) Pain subscale assesses knee pain using 9 items.
Scores are transformed to a 0-100 scale, where 0 represents extreme knee pain and 100 represents no knee pain.
Therefore, higher scores indicate a better outcome (less pain).
The primary endpoint is the change in KOOS Pain subscale score from baseline.
|
Baseline, immediately after the 2-week intervention, and 8 weeks after completion of treatment.
|
Medewerkers en onderzoekers
Sponsor
Studie record data
Bestudeer belangrijke data
Studie start (Geschat)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 41/03/2026
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .